Rhumbline Advisers Soleno Therapeutics Inc Transaction History

Rhumbline Advisers

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 05, 2021	SELL	$0.97 - $1.32 $41,317 - $56,225	-42,595 Closed	0 $0
Q1 2021 May 06, 2021	BUY	$1.24 - $3.3 $1,895 - $5,045	1,529 Added 3.72%	42,595 $54,000
Q4 2020 Feb 10, 2021	BUY	$1.61 - $2.23 $17,928 - $24,833	11,136 Added 37.21%	41,066 $79,000
Q3 2020 Nov 12, 2020	SELL	$1.71 - $2.51 $4,369 - $6,413	-2,555 Reduced 7.87%	29,930 $75,000
Q2 2020 Aug 13, 2020	BUY	$1.77 - $4.23 $57,498 - $137,411	32,485 New	32,485 $72,000

Ticker SLNO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 8,101,250
Market Cap $441M
Description
Soleno Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel therapeutics for the treatment of rare diseases. Its lead candidate is Diazoxide Choline Controlled-Release, a once-daily oral tablet for the treatment of Prader-Willi Syndrome, which is being evaluated in an ongoing P...

Get notified when there are updates to the investment portfolio of Rhumbline Advisers, based on Form 13F filings with the SEC.

Stay updated on Rhumbline Advisers with notifications on news.